Voyager Therapeutics, Inc. (VYGR)

NASDAQ: VYGR · Real-Time Price · USD

1.730

+0.030 (1.76%)

At close: Nov 13, 2026, 4:00 PM EST

1.760

+0.030 (1.73%)

After-hours: Nov 13, 2026, 7:30 PM EST

Voyager Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Assets

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep '26 Sep 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	48.41	65.3	71.37	68.8	98.96	117.43
Short-Term Investments	58.4	131.15	195.32	162.07	19.89	15.11
Cash & Short-Term Investments	106.81	196.45	266.68	230.88	118.85	132.54
Cash Growth	-48.88%	-26.34%	15.51%	94.26%	-10.33%	-26.83%
Accounts Receivable	4.27	1.91	2.18	83.49	0.26	0.73
Other Receivables	-	1	2.31	0.96	0.38	0.02
Receivables	4.27	2.92	4.49	84.46	0.64	0.75
Prepaid Expenses	3.35	0.33	0.43	0.61	0.7	1.36
Other Current Assets	-	3	5.21	3.75	4.32	2.05
Total Current Assets	114.43	202.69	276.81	319.68	124.5	136.7
Property, Plant & Equipment	34.35	41.61	47.66	30	33.34	55.38
Long-Term Investments	25.33	5.24	65.7	-	-	-
Other Long-Term Assets	2.95	2.74	2.87	1.59	1.52	1.78
Total Assets	177.05	252.28	393.05	351.28	159.36	193.86

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep '26 Sep 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Accounts Payable	1.95	5.01	4	1.6	2.57	0.57
Accrued Expenses	8.49	12.1	14.17	16.82	7.82	10.95
Current Portion of Leases	6.38	7.84	7.23	3.2	2.83	5.57
Current Unearned Revenue	-	1.59	24.39	42.88	59.38	33.89
Total Current Liabilities	16.81	26.54	49.79	64.51	72.59	50.98
Long-Term Leases	24.13	28.66	36.5	17.09	20.29	38.61
Long-Term Unearned Revenue	-	-	6	32.36	6.45	8.21
Other Long-Term Liabilities	1	1	1	1	1	1
Total Liabilities	41.94	56.2	93.29	114.96	100.34	98.8

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep '26 Sep 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Common Stock	0.06	0.06	0.06	0.04	0.04	0.04
Additional Paid-In Capital	658.69	641.9	626.3	497.51	452.71	442.26
Retained Earnings	-523.01	-445.91	-326.18	-261.18	-393.51	-347.1
Comprehensive Income & Other	-0.63	0.03	-0.41	-0.05	-0.22	-0.14
Shareholders' Equity	135.11	196.08	299.76	236.32	59.02	95.06
Total Liabilities & Equity	177.05	252.28	393.05	351.28	159.36	193.86

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep '26 Sep 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Total Debt	30.51	36.5	43.73	20.29	23.13	44.18
Net Cash (Debt)	101.63	165.19	288.66	210.58	95.72	88.36
Net Cash Growth	-46.69%	-42.77%	37.08%	119.99%	8.33%	-33.83%
Net Cash Per Share	1.69	2.81	5.01	4.72	2.50	2.35
Filing Date Shares Outstanding	62.23	59.6	55.21	54.3	43.29	38.11
Total Common Shares Outstanding	62.17	59.05	54.73	44.04	38.61	37.92
Working Capital	97.62	176.15	227.02	255.18	51.91	85.72
Book Value Per Share	2.17	3.32	5.48	5.37	1.53	2.51
Tangible Book Value	135.11	196.08	299.76	236.32	59.02	95.06
Tangible Book Value Per Share	2.17	3.32	5.48	5.37	1.53	2.51
Machinery	-	23.35	22.67	23.16	22.01	21.91
Leasehold Improvements	-	6.85	6.49	7.11	12.55	15.7

SEC Filings: 10-K · 10-Q